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The objective of this study was to make use of bovine tuberculosis suspect cattle from the state of Michigan to validate a
multiantigen print immunoassay for use on sera to serve as an improved supplementary ante-mortem test to increase speciﬁcity of
current tuberculosis testing methods. Over a 27-month period, 234 sera were collected and tested by MAPIA method, which was
evaluated using four diﬀerent interpretation criteria. These results were subsequently compared to ﬁnal mycobacterial culture and
PCR results obtained by the National Veterinary Services Laboratories, Ames, IA, which served as the true indicator of the cattle’s
tuberculosisinfectionstatus.Thisstudyindicatesthataninterpretationcriterionwhichincludes3ormorepositivereactionstothe
11 diﬀerent mycobacteria antigens utilized provided both an acceptable sensitivity (69.39%) and a high speciﬁcity (90.27%). This
MAPIA technique shows potential for eventual application as a supplementary ante-mortem tuberculosis serologic test following
one of the various current or soon-to-be-approved whole herd screening assays as part of a tuberculosis eradication program.
1.Introduction
Since the state of Minnesota has been reclassiﬁed as bovine
tuberculosis accredited free in October, 2011, there are few
USA states remaining which have endemic bovine tubercu-
losis in either its domestic cattle or a free-ranging wildlife
reservoir host [1]. Presently, only Michigan and California
are not classiﬁed as state-wide bovine tuberculosis accredit-
ed-free states. Therefore, these states are the logical locations
inwhichtoconducttrialsonneworalternativebovinetuber-
culosis assays.
The ongoing decline in bovine tuberculosis in the USA,
coupled with the ongoing economic recession, has led
the USDA to reevaluate its current approaches for bovine
tuberculosis surveillance and eradication [2]. The USDA will
now be increasing the options for managing tuberculosis-
infected herds, and developing alternative control strategies
other than whole-herd depopulation. As part of this process,
the USDA is also accelerating development of new diagnostic
tests for ante-mortem cattle testing. The rapid test or lateral
ﬂow assay is one of those new diagnostic tests for use on
bovine serum which is currently in ﬁnal stages of validation
priortoUSDAlicensureandmarketintroduction[3].Oneof
theneedsforthisnewassayisdevelopmentofasupplemental
assay to be used as a followup on cattle which are considered
as suspects or reactors to the initial rapid test, much as the
comparativecervicaltestwasusedfordecadesasasuppleme-
ntal assay on cattle which reacted to the caudal tail fold test.
Over the last three years, our laboratory has been stan-
dardizing, validating, and applying the multiantigen print
immunoassay (MAPIA) which was initially developed by
Lyashchenko and others [4]. This ante-mortem serum-based
Western blot assay utilizes several of the speciﬁc antigens
which will be included in the rapid test, therefore making it a
logical choice as the supplemental assay. All current approv-
ed ante-mortem cattle tuberculosis tests (caudal fold test,
comparative cervical test, gamma-interferon assay) are all
based on testing the cellular immune response. The MAPIA
isaserologicassaywhichteststhehumoralimmuneresponse
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bovine tuberculosis endemic in its wild white-tailed deer,
whichannuallyspillsoverintomultipledomesticcattleherds
each year, and so Michigan is a natural location in which to
investigate the speciﬁc capabilities of this assay under ﬁeld
conditions, utilizing sera from both suspect and exposed
cattle. Furthermore, while current speciﬁcity of the approv-
ed caudal fold test and comparative cervical assays have
always been reported to be in the high 90 percentiles, we
found our diagnostic laboratory was processing 10, 20, even
30 or more indemniﬁed suspectcattle to obtain a single posi-
tively infected individual [5]. Our goal in this study was to
try to develop and evaluate a supplemental ante-mortem as-
say which could signiﬁcantly reduce the false positives (i.e.,
increase speciﬁcity) that current screening methods were
producing, while still maintaining a high enough sensitivity
to move the detection and eradication process for bovine
tuberculosis forward.
2.MaterialsandMethods
2.1. Cattle. Sera were collected from live cattle submitted to
the Diagnostic Center for Population and Animal Health,
Michigan State University, by the Michigan Department of
Agriculture for tuberculosis testing as part of their ongoing
tuberculosis eradication program. Using the USDA Uniform
Methods and Rules, these cattle were classiﬁed as caudal fold
testsuspectsorreactors(CFTSuspects),comparativecervical
test suspects (CCT Suspects), gamma-interferon assay sus-
pects (IFN-γ Suspects), gamma interferon assay failed (IFN-
γ Failed), reactor cattle not otherwise speciﬁed to the initial
assay utilized (Reactor NS), traceback cattle originating from
a tuberculosis positive herd (Traceback), or cattle exposed
to a another known positive animal (Exposed) [6]. Cattle
have generally been ﬁeld testing using tuberculin between
3 and 6 weeks prior to their submission to the Diagnostic
Center, although some cattle my take as long as 2 to 4
months after ﬁeld testing before being submitted. According
to current methods, neither traceback nor exposed cattle are
required to undergo any ante-mortem tuberculosis testing
prior to removal and necropsy/slaughter. Following blood
collection, cattle were humanely euthanized and underwent
complete necropsy including collection of all major lymph
nodes from their head, thorax, and abdomen for routine
histopathology,acid-faststaining,andmycobacterialculture,
and PCR at the National Veterinary Services Laboratories,
Ames, IA [7]. The culture and PCR results provided by
NVSL served as the deﬁnitive gold standard as to whether
cattle were infected with Mycobacterium bovis or not. These
cattle were all sampled between July 1, 2009, and September
30, 2011. Exceptions to this included two cattle previously
sampled on April 30, 2001, which were in an advanced state
of tuberculosis and served as known positives for initial assay
standardization; 20 known positive sera from other states
(Nebraska, Texas, South Dakota, Colorado, and Indiana)
purchased from the USDA Tuberculosis Serum Bank to
increase the number of positive samples in the study; and
11 beef cattle with gross lesions from Michigan which went
directly to slaughter but for which the sera were collected
and the same lymph node histopathology, culture, and PCR
testing were performed at NVSL.
2.2. MAPIA. The MAPIA assay was modiﬁed slightly from
the technique previously described [4, 8] .B r i e ﬂ y ,s e r aw e r e
stored frozen at −20◦C, thawed, and diluted 1:20. Eleven
antigens were diluted to 50μg/mL in PBS, then applied by a
semiautomated airbrush-printing device (Linomat 5, Camag
Scientiﬁc Inc., Wilmington, NC, USA) onto nitrocellulose
membranes Protran Nitrocellulose Membrane (Whatman,
Dassel, Germany) in eleven 12cm long parallel strips. A blue
stain (Coomassie Blue R350, GE Healthcare, Piscataway, NJ,
USA) was also applied to the membranes to serve as an indi-
cator of the correct up-side of the membrane, to indicate the
bottom end of the membrane, and to serve as a standard
reference on each membrane with which to compare the
strength of the antigen-antibody reactions. After drying, the
membranes were cut perpendicular to the antigen strips at
approximately 4mm widths, creating test strips with 11 dif-
ferent antigen lanes plus the Coomassie Blue band. Strips
were blocked for 1hr with 1% skim milk in phosphate
buﬀered saline (PBS) with 0.05% Tween (Kirkegaard and
Perry Laboratories Inc., Gaithersburg, MD, USA), incubated
with each serum sample diluted 1:20 in PBS (Kirkegaard
and Perry Laboratories) for 2hrs, washed three times with
PBS, reacted with Protein G (Sigma-Aldrich, St. Louis, MO,
USA) for 1hr, washed 3 times, and ﬁnally reacted with
3,3 ,5,5 -tetramethylbenzidine peroxidase (TMB 1-Compo-
nent Membrane Peroxidase Substrate, Kirkegaard and Perry
Laboratories) for 5min. Strips were rinsed in cold water 3
timestostopthereactionandthenair-driedovernightbefore
being read for results. Strip results were read by unaided eye
as either negative, weak positive if the line of reactivity was
thinandlessintensethanthecontrolbandofCoomassieBlue
stain, or strong positive if the line of reactivity was as thick
and of similar intensity as the Coomassie Blue stain band.
2.3. Antigens. Antigens selected for use had been previously
reported as regularly occurring in Mycobacterium bovis or M.
tuberculosis, or as inducing signiﬁcant antibody responses in
cattle with bovine tuberculosis infections [9]. These recomb-
inant antigens included ESAT-6 [10, 11] (Statens Serum
Institut, Copenhagen, Denmark); ESAT-6/CFP10 fusion
protein [12] and MPB83 [13, 14]( p r o vi d e db yac o ll a b o ra t o r
at National Animal Disease Center, Ames, IA); Acr1 [15],
38kDa [16], 45kDa [17], Ag85B [18], GroES [19]( a l l
from TB Vaccine Testing and Research Materials Con-
tract, Colorado State University, Fort Collins, CO, USA), and
MPB59, MPB64, and MPB70 [20] (provided by a collabo-
rator at Agri-Food and Biosciences Institute, Belfast, North-
ern Ireland).
2.4. Statistical Analysis. MAPIA results were interpreted
using the NVSL mycobacterial culture and PCR results as
the true tuberculosis status of the tested cattle. Four diﬀerent
criteria for assay interpretation were developed as follows.
Criterion one is a positive reaction to any single anti-
gen; criterion two is positive reactions to any two antigens;Veterinary Medicine International 3
Table 1: Sensitivity, speciﬁcity, positive predictive value, and negative predictive value of the MAPIA test, using four diﬀerent interpretation
criteria.
MAPIA test criteria∗ Results
True status Test performance Predictive value
Positive
(n = 49)
Negative
(n = 185) Sensitivity Speciﬁcity Positive Negative
(1) Any positives Positive 48 120 97.96 35.14 28.57 98.48
Negative 1 65
(2) Two positives Positive 46 52 93.88 71.89 46.94 97.79
Negative 3 133
(3) Three positives Positive 34 18 69.39 90.27 65.38 91.76
Negative 15 167
(4) Any strong positive Positive 29 22 59.18 88.11 56.86 89.07
Negative 20 163
∗Test criteria.
(1) Any positives: weak or strong positive reaction to at least one antigen
(2) Two positives: weak or strong positive reaction to at least two antigens
(3) Three or more positives: weak or strong positive reaction to at least three antigens
(4) Any strong positive: strong positive reaction to at least one antigen.
Table 2: Sensitivity, speciﬁcity, positive predictive value, and negative predictive value of a weak or strong positive reaction to at least three
antigens (criterion 3) in the MAPIA test, by diﬀerent antecedent tests.
MAPIA test criteria∗ Results
True status Test performance Predictive value
Positive
(n = 49)
Negative
(n = 185) Sensitivity Speciﬁcity Positive Negative
CFT suspect/reactor Positive 11 2 84.62 92.31 84.62 92.31
Negative 2 24
CCT suspect Positive 1 2 50.0 90.91 33.33 95.24
Negative 1 20
IFN-γ suspect Positive 12 10 70.59 81.82 54.54 90.0
Negative 5 45
Traceback Positive 0 4 — 80.0 — 100.0
Negative 0 16
Exposed Positive 0 0 — 100.0 — 100.0
Negative 0 58
criterionthreeispositivereactionstoany3ormoreantigens;
and criterion four is a strong positive reaction to any
single antigen. Each of these was then calculated for sensi-
tivity, speciﬁcity, and positive or negative predictive values.
In addition, each individual antigen was evaluated for sensi-
tivity, speciﬁcity, positive and negative predictive values.
3. Results
Of the 234 cattle tested for this study, 49 were true positive
cattle based on mycobacterial positive cultures and PCR
positive results for M. bovis at the NVSL, Ames, IA. The
authors acknowledge that some positive cattle in very early
stages of infection may not have exhibited gross or histologic
lesions of tuberculosis and may not have been detected by
current culture methods; however, for the purposes of this
study true positive cattle must have positive mycobacterial
culture or PCR results. The remaining 185 cattle were true
negatives based on negative PCR and culture results.
Four criteria were used to evaluate the MAPIA results as
previously described in the methods. Of these, criteria 1, 2,
and 3 all provided good sensitivities compared to the true
positive status of the individual cattle tested (see Table 1).
But criterion 3 provided by far the best speciﬁcity of 90.27%,
which was signiﬁcantly better than either criterion 1 or 2. In
addition, using positive predictive value, criterion 3 was the
best criteria correctly identifying nearly two-thirds of all true
positive animals as positive, while both criteria 1 and 2 had
signiﬁcantly lower positive predictive values. Therefore, for
our current situation in Michigan, criterion 3 proved to be
the best method for using the MAPIA assay.
Table 2 illustrates how criterion 3 correlates with each of
the antemortem categories of cattle (CFT suspects, CTT sus-
pects, IFN-γ suspect, etc.). This criterion correlates best with
CFT suspect/reactors and IFN-γ suspects, while it does not
c o rr e l a t ea sw e llwi t hC C Ts u s pe ct s .T h e r ew e r en otru ep o s i -
tive cattle in the traceback and exposed cattle, so the method
cannot be meaningfully evaluated for its performance in
these categories. Nor were cattle in this study included in4 Veterinary Medicine International
Table 3: Sensitivity, speciﬁcity, positive predictive value, and negative predictive value of weak or strong positive reactions to individual
antigens used in MAPIA.
Antigen Results
True status Test performance Predictive value
Positive
(n = 49)
Negative
(n = 185) Sensitivity Speciﬁcity Positive Negative
ESAT-6 Positive 41 97 83.67 47.57 29.71 91.67
Negative 8 88
ESAT-6/CFP10 Positive 43 55 87.76 70.27 43.88 95.59
Negative 6 130
Acr1 Positive 13 9 26.53 95.14 59.09 83.02
Negative 36 176
38kDa Positive 2 1 4.08 99.46 66.67 79.65
Negative 47 184
45kDa Positive 24 21 48.98 88.65 53.33 86.77
Negative 25 164
Ag85B Positive 5 3 10.20 98.38 62.50 80.53
Negative 44 182
GroES Positive 14 8 28.57 95.68 63.64 83.49
Negative 35 177
MPB83 Positive 3 0 6.12 100.0 100.0 80.09
Negative 46 185
MPB59 Positive 1 0 2.04 100.0 100.0 79.40
Negative 48 185
MPB64 Positive 2 0 4.08 100.0 100.0 79.74
Negative 47 185
MPB70 Positive 24 3 48.98 98.38 88.89 87.92
Negative 25 182
Table 2 if their initial method of ﬁeld testing (CFT, CCT,
IFN-γ) were not known.
Table 3 compares the sensitivity, speciﬁcity, and positive
and negative predictive values for each of the 11 speciﬁc
antigens used in our MAPIA assay. While ESAT-6 and the
ESTA-6/CFP10 fusion protein had the highest sensitivities
(83.67% and 87.76% resp.), these two antigens also demon-
strated the lowest speciﬁcities (47.57% and 70.27% resp.).
The other 9 remaining antigens tested exhibited signiﬁcantly
lower sensitivities, but also uniformly higher speciﬁcities.
4. Discussion
MAPIA assay in our laboratory, compared to known positive
and negative bovine tuberculosis infected cattle primarily
from the state of Michigan, oﬀers promise as a supplemental
test. The MAPIA assay requires some specialized equipment,
some moderately expensive reagents, and approximately 4.5
hours of time to run. The time, equipment, cost all make this
assay less than optimal for whole herd screening. But as a
follow-up or supplemental test, especially for the CFT, this
assay when interpreted using criterion 3 oﬀers high sensi-
tivity (84.62%) and high speciﬁcity (92.31%). This in turn
can lead to large monetary savings to state and federal
agencies by signiﬁcantly reducing the total number of
cattle indemniﬁed, transported to necropsy facilities, and
undergoing extensive post-mortem testing.
For example on the cost savings, and using the 234 cattle
included in this study as an example, if we had run the
MAPIA before sacriﬁcing these cattle, only 78 would have
beenconsideredsuspectsandsenttonecropsyusingcriterion
3. The MAPIA costs between $100 and $150 to run including
reagents, technician time, and so forth. Multiplying 234
cattle sera by $150 results in an additional cost of doing
this supplemental test of $35,100. Now we calculate the
cost of sacriﬁcing those other 156 cattle which the MAPIA
would have classiﬁed as not suspects. Maximum indemnity
in Michigan is currently $3500 per cow; we will take $1750 as
anestimateattheaverageindemnitycostofacow.Addinthe
state of Michigan paying for a 4-hour hauling charge from
the endemic tuberculosis area to the laboratory, estimated
at $150 per cow, the Diagnostic Laboratory charge of $250
per cow for full tuberculosis surveillance workup, and the
additional charges incurred by the USDA for mycobacterial
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nodes estimated at $450 per cow. This totals to an average
cost of $2,600 per cow. Multiplying 156 cattle by the average
cost of $2,600 we get an additional cost of $405,600. The
extra cost of $35,100 for the additional MAPIA testing, is
more than oﬀset by the additional cattle costs of $405,600,
resulting in a net savings of $370,500. This is not a perfect
result as 12 true positive cattle would have remained on their
farms since MAPIA criterion 3 did not call them positive.
However, this assay can be interpreted by various criteria.
Criterion 1 would have only missed one positive cattle, and
criterion 2 would have only missed three positive cattle; but
both criteria would have required the sacriﬁce of additional
cattle, resulting in lower total monetary savings. Remember
that each state could select the MAPIA interpretation which
makes the most sense for their situation. In Michigan, you
mightreasonablyselectcriterion1tomissthelowestnumber
of positive cattle since tuberculosis is present in both the
cattle and wildlife populations. Most of the US states are free
oftuberculosisandcouldselectamorespeciﬁcinterpretation
criterion by which to use the MAPIA. The interpretation
could also be adjusted depending on the area the cattle were
in (accredited free, modiﬁed accredited free, etc.), or if the
farm was known to have other currently infected animals or
if the farm had previously contained infected animals then
more sensitive criterion could be used.
Several researchers have indicated that ESAT-6 or ESAT-
6/CFP10 are among the best antigens to be used for ante-
mortem serologic testing for tuberculosis [9–12, 21]. Our
data indicates that these two antigens do detect the highest
percentages of true positive tuberculous cattle and result
in the highest sensitivity. However, our results also show
relatively low speciﬁcity for both antigens due to many false
positives. These antigens may not be as speciﬁc for Mycob-
acterium bovis as previously believed. Alternatively, they
are secreted so early in the immune response that they may
increase rapidly following the intradermal injection of tuber-
culin utilized in the CFT or CCT tests, therefore resulting in
false positives. One recent study actually documented a sig-
niﬁcant boost in BCG-vaccinated cattle following the use of
the intradermal tuberculin test, resulting in increased immu-
noglobulin levels of eight diﬀerent mycobacterial antigens
when measured by the MAPIA [9]. Whatever the reason, all
9 of the other antigens utilized in this study had signiﬁcantly
higher speciﬁcities (ranging from 88.65% up to 100%), but
also signiﬁcantly lower sensitivities (ranging from 2.04% to
48.98%). It is interesting to note of the 9 antigens evaluat-
ed other than ESAT-6 and ESTA-6/CFP10, the two antigens
showing the highest sensitivity were 45kDA and MPB70
(both had sensitivities of 48.98%). MPB70 has been
previously shown to have high sensitivity in detecting tuber-
culous cattle in surveys conducted in a number of countries
[21]. Therefore, by using a criterion for MAPIA interpre-
tation which combines multiple antigen reactions, one
gains increased speciﬁcity while maintaining high overall
sensitivity.
Lookingforstrongerpositivereactionsasincriterion4in
theMAPIAdidnotresultinincreasedsensitivity,butactually
decreased sensitivity (59.18%) to the lowest of all four crite-
ria used. This may reﬂect the less important role of antibody
responseintuberculosisinfectioncomparedtocell-mediated
immunity; therefore, infected cattle may not necessarily
develop the highest antibody response against mycobacterial
antigens. For whatever reason, strength of antibody-anti-
gen reaction was not highly correlated with true tuberculosis
status.Forthisreason,theauthorschosetosimplifytheread-
ing and reporting of the assay to three simple responses, neg-
ative, weak, or strong and not to include quantitative opti-
cal density measurements for each antigen-antibody reac-
tion within the MAPIA assay as in some previous studies [4].
One interesting side note is how this MAPIA assay was
performed in cattle which were negative for M. bovis,b u t
from which environmental mycobacteria outside the M.
tuberculosis-group were isolated. Only four cattle out of 234
were culture positive for either M. avium (2 isolates) or non-
M. tuberculosis group (2 isolates), not otherwise speciﬁed. So
the numbers are too low to make any generalizations about
how the MAPIA assay performs. However, these 4 cattle were
uniformly interpreted negative on MAPIA testing by criteria
2,3,and4;while2of4cattle(bothnon-M.tuberculosisgroup
individuals)wereinterpretedpositivebycriterion1.Thisrei-
nforces the value to utilizing an interpretation criterion that
includes more than one positive response as a method to
increase the test speciﬁcity.
Ideally,ourevaluationofMAPIAwillcontinue,withtest-
ing of additional known positive and negative cattle. In
addition,ifthisassayistosomedaybeapprovedbyUSDAasa
supplementaltest,wewouldideallyliketorunallourbanked
sera samples by the rapid test—lateral ﬂow assay. That
assay—as previously stated—is in the approval process for
validationandlicensureforuseintheUS[3].Sincethatassay
utilizes several of the same antigens as the MAPIA, and is an
ante-mortem serologic assay, it would be important to com-
pare these two assays performance on the same set of sera.
However, since the rapid test is not yet approved, and there-
forenotcommerciallyavailable,wehavebeenunabletocom-
plete this important validation step to date.
The MAPIA assay requires some specialized equipment,
some moderately expensive reagents, and approximately 4.5
hours of time to run. However, with the proper application
of methods, selection of test antigens, and correct inter-
pretation criteria, it shows remarkable promise for use as
limited supplemental test following initial ante-mortem ﬁeld
screening tests. While the MAPIA is currently too expensive
touseasaprimaryscreeningtestfortuberculosisincattle,its
use to either increase sensitivity or speciﬁcity depending on
the speciﬁc needs of the state, area or farm, when used as a
supplemental test, could prove valuable as an epidemiologic
tool, and potentially result in signiﬁcant cost savings for the
national tuberculosis eradication program.
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